JLPSX
Price
$25.18
Change
-$0.23 (-0.91%)
Updated
Jul 13 closing price
Net Assets
3.7B
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

JLPSX vs VSTSX

JLPSX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
JLPSX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JLPSX is a Buy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. JLPSX (3.7B). VSTSX pays higher dividends than JLPSX: VSTSX (1.07) vs JLPSX (0.18). JLPSX was incepted earlier than VSTSX: JLPSX (21 years) vs VSTSX (10 years). JLPSX (1.69) is less costly to investors than VSTSX (0.01). JLPSX is a more actively managed with annual turnover of: 100.00 vs. VSTSX (3.00). JLPSX has a lower initial minimum investment than VSTSX: JLPSX (1000000) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.48 vs. JLPSX (13.16). VSTSX return over 5 years is better than : 66.56 vs. JLPSX (-9.19).
JLPSXVSTSXJLPSX / VSTSX
Total Expense Ratio1.390.0113,900%
Annual Report Gross Expense Ratio1.690.0116,900%
Fund Existence21 years10 years-
Gain YTD7.99011.20571%
Front LoadN/AN/A-
Min. Initial Investment100000050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.7B2.3T0%
Annual Yield % from dividends0.181.0716%
Returns for 1 year13.1621.4861%
Returns for 3 years42.2367.0663%
Returns for 5 years-9.1966.56-14%
Returns for 10 years-4.88239.53-2%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I